Meghmani Organics Ltd(Merged)
Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber.
It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage. [1]
In 2009, Meghmani Finechem Ltd (MFL), subsidiary of MOL also commissioned its caustic soda plant, which has the capacity of 294,000 tonnes per annum and is powered by a 96-megawatt captive power plant. [2]
- Market Cap ₹ 2,270 Cr.
- Current Price ₹ 138
- High / Low ₹ /
- Stock P/E 10.6
- Book Value ₹ 42.6
- Dividend Yield 0.00 %
- ROCE 22.2 %
- ROE 21.2 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 46.0% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
768 | 729 | 865 | 822 | 750 | 893 | 948 | 959 | 1,046 | 1,234 | 1,410 | 1,625 | 1,570 | |
670 | 637 | 774 | 747 | 697 | 816 | 848 | 847 | 913 | 1,060 | 1,174 | 1,387 | 1,271 | |
Operating Profit | 98 | 93 | 91 | 75 | 53 | 77 | 100 | 112 | 133 | 174 | 236 | 238 | 300 |
OPM % | 13% | 13% | 11% | 9% | 7% | 9% | 11% | 12% | 13% | 14% | 17% | 15% | 19% |
3 | 22 | 7 | 9 | 9 | 4 | 15 | 16 | 7 | 21 | 78 | 77 | 65 | |
Interest | 24 | 14 | 17 | 28 | 27 | 35 | 48 | 41 | 36 | 31 | 46 | 31 | 31 |
Depreciation | 15 | 17 | 20 | 26 | 26 | 31 | 35 | 36 | 38 | 43 | 46 | 48 | 49 |
Profit before tax | 62 | 84 | 60 | 30 | 9 | 15 | 32 | 50 | 65 | 121 | 222 | 235 | 285 |
Tax % | 19% | 26% | 21% | 46% | 34% | 21% | 19% | 27% | 37% | 37% | 24% | 18% | |
51 | 62 | 47 | 17 | 6 | 12 | 26 | 36 | 42 | 77 | 169 | 193 | 218 | |
EPS in Rs | 1.99 | 2.42 | 1.86 | 0.65 | 0.23 | 0.46 | 1.03 | 1.43 | 1.63 | 3.03 | 6.63 | 7.59 | 8.58 |
Dividend Payout % | 17% | 17% | 22% | 15% | 44% | 22% | 39% | 21% | 24% | 13% | 15% | 13% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 11% |
3 Years: | 16% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 46% |
3 Years: | 64% |
TTM: | 28% |
Stock Price CAGR | |
---|---|
10 Years: | 18% |
5 Years: | 20% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 14% |
3 Years: | 18% |
Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Reserves | 423 | 472 | 508 | 502 | 509 | 514 | 541 | 566 | 607 | 672 | 813 | 965 |
190 | 249 | 324 | 327 | 376 | 435 | 387 | 388 | 338 | 421 | 327 | 264 | |
156 | 163 | 177 | 179 | 219 | 265 | 201 | 217 | 221 | 259 | 339 | 389 | |
Total Liabilities | 795 | 909 | 1,034 | 1,033 | 1,130 | 1,240 | 1,155 | 1,197 | 1,192 | 1,378 | 1,504 | 1,644 |
141 | 146 | 191 | 248 | 257 | 371 | 388 | 383 | 384 | 448 | 439 | 481 | |
CWIP | 9 | 43 | 46 | 53 | 89 | 21 | 16 | 23 | 16 | 25 | 49 | 101 |
Investments | 110 | 130 | 148 | 114 | 138 | 138 | 139 | 125 | 125 | 234 | 183 | 183 |
534 | 590 | 649 | 618 | 646 | 710 | 613 | 667 | 667 | 672 | 832 | 879 | |
Total Assets | 795 | 909 | 1,034 | 1,033 | 1,130 | 1,240 | 1,155 | 1,197 | 1,192 | 1,378 | 1,504 | 1,644 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
99 | 37 | 77 | 81 | 68 | 48 | 142 | 79 | 115 | 178 | 115 | 234 | |
-27 | -74 | -106 | -34 | -59 | -80 | -32 | -33 | -28 | -218 | -59 | -93 | |
-26 | 36 | 41 | -46 | -16 | 41 | -104 | -49 | -88 | 40 | -56 | -134 | |
Net Cash Flow | 46 | -1 | 11 | 1 | -7 | 8 | 5 | -3 | -0 | 0 | 1 | 6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 141 | 162 | 137 | 143 | 160 | 135 | 116 | 112 | 104 | 90 | 92 | 104 |
Inventory Days | 77 | 91 | 82 | 92 | 111 | 135 | 114 | 175 | 119 | 120 | 164 | 108 |
Days Payable | 54 | 72 | 70 | 66 | 101 | 105 | 80 | 108 | 88 | 88 | 100 | 85 |
Cash Conversion Cycle | 164 | 180 | 150 | 169 | 170 | 165 | 150 | 179 | 135 | 122 | 155 | 127 |
Working Capital Days | 181 | 212 | 193 | 211 | 217 | 199 | 163 | 176 | 153 | 128 | 133 | 111 |
ROCE % | 18% | 14% | 10% | 7% | 4% | 5% | 9% | 10% | 11% | 15% | 20% | 22% |
Documents
Announcements
- Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th August, 2021. 10 Aug 2021
- Board Meeting Intimation for Intimation Of The Board Meeting Of Meghmani Organics Limited (Formerly Known As Meghmani Organochem Limited) ('Company') Scheduled To Be Held On 10Th August, 2021. 3 Aug 2021
- Announcement under Regulation 30 (LODR)-Investor Presentation 3 Jul 2021
-
Announcement under Regulation 30 (LODR)-Investor Presentation
24 May 2021 - Meghmani submits Investor Presentation on the Financials for the quarter and year ended 31st March, 2021 of Meghmani Organochem Limited.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May 2021 - Revised Investor Presentation on the Financials for the quarter and year ended 31st March, 2021 of Meghmani Finechem Limited.
Annual reports
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from nse
Concalls
-
Jul 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptPPT
-
Feb 2017Transcript PPT
-
Nov 2016TranscriptPPT
-
Nov 2016Transcript PPT
-
Aug 2016Transcript PPT
-
Nov 2015TranscriptNotesPPT
-
Aug 2015TranscriptNotesPPT
Pigments (29% of revenue) [1]
The company is amongst the top 3 global Phthalocyanine based pigment players. 14% global market share.
3 vertically integrated Manufacturing facilities [2]
The company is trying to expand into new geographies and explore new pigments. The company has strong client relationships (90% business from repeat clients). The high degree of product customization, consistent quality, and compliance regulations add to client stickiness